← Leaderboards
Cheryl Stoddart
J. David Gladstone Institutes
$14,886,148
Attributed
$14,886,148
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2007–22$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$14,886,148 · 6
By mechanism
N01$13,200,920 · 3
R21$961,774 · 2
R56$723,454 · 1
Top collaborators
No co-investigators on record.
Most similar at J. David Gladstone Institutes
Same institution · by research overlap
- Douglas F Nixon$54,453,314
- Melanie Maria Ott$58,597,956
- Jj Miranda$1,429,568
- Robyn Midori Kaake$484,887
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsMouse ModelIn VitroResourcesHumanized MouseIn VivoAnimal ModelContractsTherapeutic DevelopmentNational Institute Of Allergy And Infectious DiseaseDrug DiscoveryAftercareIntegration Host FactorsIn Vitro ActivityLengthNonhuman PrimateDrug EvaluationDisease RemissionInnovationComplementCd4 Positive T LymphocytesHeat-Shock ResponseHeat-Shock Proteins 90Cells
Grant awards (14)
Single-chain antibodies to block HIV transcription and prevent reactivation from latently infected resting CD4+ T cells$201,875
R21 · FY2022 · AI · contact PI
Single-chain antibodies to block HIV transcription and prevent reactivation from latently infected resting CD4+ T cells$242,250
R21 · FY2021 · AI · contact PI
Inhibition of heat shock protein 90 for sustained remission of HIV from persistent tissue reservoirs$723,454
R56 · FY2020 · AI · contact PI
HUMANIZED MOUSE MODELS FOR HIV THERAPEUTICS DEVELOPMENT$1,042,164
N01 · FY2019 · AI · contact PI
HUMANIZED MOUSE MODELS FOR HIV THERAPEUTICS DEVELOPMENT$2,018,293
N01 · FY2018 · AI · contact PI
"HUMANIZED MOUSE MODELS FOR HIV THERAPEUTICS DEVELOPMENT"$1,953,904
N01 · FY2017 · AI · contact PI
IGF::OT::IGF "HUMANIZED MOUSE MODELS FOR HIV THERAPEUTICS DEVELOPMENT"$1,871,804
N01 · FY2016 · AI · contact PI
IGF::OT::IGF "HUMANIZED MOUSE MODELS FOR HIV THERAPEUTICS DEVELOPMENT"$1,997,581
N01 · FY2015 · AI · contact PI
IGF::OT::IGF "HUMANIZED MOUSE MODELS FOR HIV THERAPEUTICS DEVELOPMENT"$1,713,214
N01 · FY2014 · AI · contact PI
Heat shock protein 90 and HIV persistence$296,396
R21 · FY2014 · AI · contact PI
Heat shock protein 90 and HIV persistence$221,253
R21 · FY2013 · AI · contact PI
Tissue Based Small Animal Model for HIV Drug Discovery$164,107
N01 · FY2009 · AI · contact PI
TISSUE BASED SMALL ANIMAL MODEL FOR HIV DRUG DISCOVERY$1,469,166
N01 · FY2007 · AI · contact PI
TISSUE-BASED SMALL ANIMAL MODEL FOR HIV DRUG DISCOVERY$970,687
N01 · FY2000 · AI